The 8-year cumulative incidence of a composite of cardiovascular death, heart failure hospitalization, ischemic stroke, or major bleeding according to the symptom status and previous AF-related complications.

HR = hazard ratio; LVEF = left ventricular ejection fraction.</p

Baseline characteristics of asymptomatic and symptomatic AF patients with and without previous AF-related complications.

(DOCX)</p

Baseline characteristics comparing conservative versus ablation groups in asymptomatic and symptomatic AF patients.

Baseline characteristics comparing conservative versus ablation groups in asymptomatic and symptomatic AF patients.</p

The Kaplan-Meier curves for the cumulative incidence of the primary outcome measure defined as a composite of cardiovascular death, heart failure hospitalization, ischemic stroke, or major bleeding in asymptomatic and symptomatic AF patients.

AF = atrial fibrillation; HR = hazard ratio.</p

Baseline characteristics according to AF symptom grades.

(DOCX)</p

Baseline characteristics comparing conservative and ablation groups in asymptomatic AF patients with and without previous AF-related complications.

(DOCX)</p

EHRA symptom grades and the prevalence of previous AF-related complications.

AF = atrial fibrillation; EHRA = European Hear Rhythm Association.</p

Clinical outcomes in asymptomatic AF patients of the ablation group comparing those with and without previous AF-related complications.

A) Event free rate from recurrent atrial tachyarrhythmias with a blanking period of 90 days after procedure. B) Discontinuation of OAC. AF = atrial fibrillation; OAC = oral anticoagulation. (PPTX)</p

Clinical outcomes comparing asymptomatic and symptomatic AF patients in the ablation group.

A) Event free rate from recurrent atrial tachyarrhythmias with a blanking period of 90 days after procedure. B) Discontinuation of OAC. AF = atrial fibrillation; OAC = oral anticoagulation. (PPTX)</p

Details of ablation procedure.

(DOCX)</p